Risk Factors for Overdose in Young People Who Received Substance Use Disorder Treatment.
Autor: | Yule AM; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Carrellas NW; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., DiSalvo M; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Lyons RM; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., McKowen JW; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Nargiso JE; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Bergman BG; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Kelly JF; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Wilens TE; Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Addiction Recovery Management Service, Center for Addiction Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. |
---|---|
Jazyk: | angličtina |
Zdroj: | The American journal on addictions [Am J Addict] 2019 Sep; Vol. 28 (5), pp. 382-389. Date of Electronic Publication: 2019 Jul 10. |
DOI: | 10.1111/ajad.12938 |
Abstrakt: | Background and Objectives: To identify substance and psychiatric predictors of overdose (OD) in young people with substance use disorders (SUDs) who received treatment. Methods: We conducted a retrospective review of consecutive medical records of young people who were evaluated in a SUD program between 2012 and 2013 and received treatment. An independent group of patients from the same program who received treatment and had a fatal OD were also included in the sample. OD was defined as substance use associated with a significant impairment in level of consciousness without intention of self-harm, or an ingestion of a substance that was reported as a suicide attempt. t Tests, Pearson's χ 2 , and Fisher's exact tests were performed to identify predictors of OD after receiving treatment. Results: After initial evaluation, 127 out of 200 patients followed up for treatment and were included in the sample. Ten (8%) of these patients had a nonfatal OD. Nine patients who received treatment and had a fatal OD were also identified. The sample's mean age was 20.2 ± 2.8 years. Compared with those without OD, those with OD were more likely to have a history of intravenous drug use (odds ratio [OR]: 36.5, P < .001) and mood disorder not otherwise specified (OR: 4.51, P = .01). Discussion and Conclusions: Intravenous drug use and mood dysregulation increased risk for OD in young people who received SUD treatment. Scientific Significance: It is important to identify clinically relevant risk factors for OD specific to young people in SUD treatment due to the risk for death associated with OD. (Am J Addict 2019;28:382-389). (Copyright © 2019 American Academy of Addiction Psychiatry.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |